ResearcherFirst Affiliated Hospital of Anhui Medical UniversityActive in the last 2 years

Yu Zhang

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0000-0002-2614-5975; OpenAlex author ID A5063077523.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers: 1 (first author 0, last author 1)
Pancreatic cancer trials: 0
Pancreatic cancer grants: 0
Collaborators: 2

Papers, trials and grants by year

2026: 1 paper

Papers 1

TRIM29 promotes pancreatic cancer MVI via IκBα K48-ubiquitination and NF-κB activation in CXCL5⁺ epithelial cells. Last author DOI 10.1186/s12943-026-02652-3 ↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Liu Long · 1 shared paper, 2026
- Paper TRIM29 promotes pancreatic cancer MVI via IκBα K48-ubiquitination and NF-κB activation in CXCL5⁺ epithelial cells. DOI 10.1186/s12943-026-02652-3 ↗
Sheng Yan · 1 shared paper, 2026
- Paper TRIM29 promotes pancreatic cancer MVI via IκBα K48-ubiquitination and NF-κB activation in CXCL5⁺ epithelial cells. DOI 10.1186/s12943-026-02652-3 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.